SuperworthCuris market cap CRIS
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $807.4K
- Highest close in our data
- $1.3B
- May 2021
Curis is worth $807.4K at the close on Oct 23, 2026, at $0.39 a share.
That is down 96% over the last year and down 100% over five years.
Its highest close in our data was $1.3B in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $807.4K | $807.4K | $24.1M | −94% |
| 2025 | $13.7M | $9.9M | $32.8M | −50% |
| 2024 | $27.5M | $25M | $99M | −63% |
| 2023 | $75.1M | $23.2M | $91.3M | +42% |
| 2022 | $53M | $47.6M | $334.4M | −88% |
| 2021 | $436.1M | $411.3M | $1.3B | −9% |
| 2020 | $481.7M | $23.8M | $481.7M | +836% |
| 2019 | $51.5M | $29M | $81.3M | +105% |
| 2018 | $25.1M | $24.9M | $137.5M | −78% |
| 2017 | $114.8M | $114.8M | $442.7M | −73% |
| 2016 | $432.9M | $182.3M | $473.7M | +16% |
| 2015 | $373.6M | $117.8M | $478.1M | +237% |
| 2014 | $110.9M | $100.6M | $284M | −54% |
| 2013 | $241.1M | $217.9M | $372.5M | −11% |
| 2012 | $271.9M | $243.9M | $426.7M | −24% |
| 2011 | $358.4M | $214.3M | $358.4M | n/a |
Against its peers
Companies in Biotechnology nearest Curis' size, closest first, today.
| Company | Market cap |
|---|---|
| CRISCuris | $807.4K |
| SLXNSilexion Therapeutics | $1M |
| CLDICalidi Biotherapeutics | $1.6M |
| VIVSVivoSim Labs, INC. | $2.2M |
| PMCBPharmaCyte Biotech | $3.8M |
| LIMNLiminatus Pharma | $3.9M |
| AIMAIM ImmunoTech | $4.8M |
| CELZCreative Medical Technology | $4.9M |
| SNTISenti Biosciences | $5.9M |
| INABIN8BIO | $10.4M |
| INTSIntensity Therapeutics | $10.6M |
| Peer median | $4.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Curis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.